India is already a global pharmaceutical hub and is on the verge of a breakthrough in biotechnology drugs. Indian biotech companies are working on 225 new molecules, a sixth of which are so-called first-in-class drugs—that is, a completely new drug or mechanism for treating a disease or disorder. To break it down, Manta is doing a six-part story series on India's biotech companies. Why is this important and what exactly is happening in this space? expect.